CN Patent
CN101227942A — 具有剂量限制机构和另外的安全机构的注射器设备
Assigned to Novo Nordisk AS · Expires 2008-07-23 · 18y expired
What this patent protects
一种用于排出一定剂量的药品的注射器设备,该注射器设备包括:剂量限制机构,其布置为与剂量排出机构相互作用,以防止排出超过设定剂量的剂量;和安全机构,其相对于剂量排出机构布置为使得如果剂量限制机构失效,则安全机构防止排出超过设定剂量的剂量。
USPTO Abstract
一种用于排出一定剂量的药品的注射器设备,该注射器设备包括:剂量限制机构,其布置为与剂量排出机构相互作用,以防止排出超过设定剂量的剂量;和安全机构,其相对于剂量排出机构布置为使得如果剂量限制机构失效,则安全机构防止排出超过设定剂量的剂量。
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.